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Several studies have reported biological vascular grafts to be more resistant to microbial infection than
synthetic counterparts in vivo. Indeed, small intestinal submucosa (SIS) materials have previously been
reported to be antimicrobial. The aim of this study was to assess the antimicrobial activity and the ability
to resist bioﬁlm formation of a novel acellular vascular graft and compare it to commercially available
alternatives using a range of organisms: MRSA, MSSA, Staphylococcus epidermidis, Enterococcus faecalis,
Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa and Candida albicans. This was achieved
using a modiﬁed disk diffusion assay and extraction of the materials into solution followed by minimum
inhibitory concentration assays. To assess resistance to bioﬁlm formation a novel bioﬁlm assay was
developed which compared the total colony forming units (CFU) recovered from each material and
identiﬁcation of the percentage of CFU which were loosely attached, residing within the bioﬁlm or
attached to the biomaterial. The results indicated a lack of antimicrobial activity for all materials tested,
including SIS. The biological materials were more resistant to the formation of a bioﬁlm compared to
Dacron.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Vascular grafts are commonly used to replace or bypass diseased
or non functional vessels. The gold standard vascular graft is an
autograft such as the saphenous vein. Autografts have good long
term patency (above knee bypass 70e80% patency at ﬁve year
follow up) and demonstrate anti-thrombogenic properties.1,2 In
10e40% of patients however, there is no suitable autograft to
harvest, due to arterial disease or trauma.3 Synthetic materials such
as Dacron or expanded polytetraﬂuroethane (ePTFE) have been
used for decades in medium and large diameter vessels with
acceptable clinical results. In small diameter grafts (<6 mm)
synthetic materials have not been as successful, with long term
patencies reported as low as 49% at ﬁve year follow up.2 Synthetic
materials also demonstrate a high propensity for infection, early
studies reported an infection rate four times higher than saphenous
vein.4 Once implanted synthetic materials provide a site for bioﬁlm
formation, protecting microbes from the effects of antibiotics.
Vascular graft infections are a devastating complication of
vascular graft insertions. Thankfully they are rare (1e5% of graftsciety for Vascular Surgery. Publishebecome infected), but in these cases there is little option for the
surgeon but to replace the graft through an uninfected ﬁeld.5 Graft
infections can result in limb loss or death due to the tendency of
organisms to form bioﬁlms, which are difﬁcult to treat. There is
a clinical need therefore for infection resistant vascular conduits or
grafts. To address this, some synthetic conduits are available pre-
loaded with antimicrobials. Examples include gelatin sealed poly-
ester grafts (Gelseal graft: Vascutek) soaked in solutions of rifampin
and ePTFE grafts loaded with silver acetate (Interguard silver ultra
thin vascular prosthesis) although there is controversy in their
efﬁcacy in reducing infections. These conduits exhibit the disad-
vantages of synthetic materials when used in small diameter
vessels including thrombogenicity and less than ideal patency rates
at ﬁve year follow up. It has been reported that biological vascular
grafts, such as small intestinal submucosa (SIS), are naturally more
resistant to infection than synthetic alternatives, with claims of
antimicrobial activity.6 We have developed acellular vascular bio-
logical scaffold conduit derived from porcine arteries using
proprietary methods which are currently under pre-clinical eval-
uation.7,8 The aim of this study was to assess the antimicrobial
activity of decellularised vascular conduits and compare this to
both a biological graft (SIS) and synthetic vascular materials
(Dacron  and ePTFE).d by Elsevier Ltd. All rights reserved.
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Commercial materials
Synthetic materials used were Dacron (Unigraft from Braun)
and ePTFE (impra from Bard peripheral vascular inc). Small
intestinal submucosa (SIS) was purchased from Cook Biomedical.
Procurement of external iliac arteries
External iliac arteries (EIA) were retrieved from adult female
white pigs (aprox 120 kg) sourced from the University of Leeds
farm. The tunica adventitia was removed via blunt dissection and
the vessel washed three times in sterile Dulbecco’s phosphate
buffered saline (DPBSa) (Oxiod, Basingstoke, UK) containing 0.1%
(w/v) EDTA (VWR, Lutterworth, UK). Tissues were stored at 80 C
until required. Comparisons were made between acellular vessels
and fresh vessels, which were 9e12 cm in length and had internal
diameters of 2e5 mm. The decellularisation procedure has been
described elsewhere.9
Decellularisation validation
Tissue processing and histological evaluation
Sections of formalin ﬁxed acellular EIA and fresh controls were
stained using Myers haematoxylin and eosin (H&E, Raymond A
Lamb Ltd, Eastbourne, UK) to evaluate the tissue architecture, and
DAPI dye (40, 6-diamiidino-2-phenylindole, Invitrogen, Paisley, UK)
to visualize cell nuclei. Sections were viewed using an Olympus BX
51 microscope (Olympus, Southend-on-Sea, UK); and images
captured digitally.
DNA extraction and quantiﬁcation
DNA was extracted from 25 mg of fresh and acellular tissue
(n ¼ 3) using the DNeasy kit purchased from Qiagen (Qiagen,
Crawley, UK). Themanufactures instructions were followed and the
DNA was quantiﬁed using a Nanodrop spectphotometer (ND-1000,
Thermo Fischer Scientiﬁc, Loughborough, UK).
Cytotoxicity studies
To ensure any microbial inhibition observed was due to anti-
microbial activity of the conduits and not due to cytotoxicity
following decellularisation, contact and extract cytotoxicity tests
were performed.
Cell culture
3T3murine ﬁbroblasts (Health Protection Agency, Salisbury, UK)
were cultured in Dulbecco’s modiﬁed Eagles medium (DMEM)
containing 10% (v/v) foetal calf serum, 100 U ml1 penicillin,
100 mg ml1 streptomycin and 2 mM L-glutamine (Lonza, Cam-
bridge, UK) at 37 C in 5% (v/v) CO2 in air. The mediumwas changed
every two days.
Baby hamster kidney (BHK) cells (Health Protection Agency)
were cultured in Glasgow’s modiﬁed Eagles medium (GMEM)
containing 5% (v/v) foetal calf serum, 2.5% (w/v) tryptose phosphate
broth (Oxoid), 100 U ml1 penicillin, 100 mg ml1 streptomycin and
2 mM L-glutamine (Lonza) at 37 C in 5% (v/v) CO2 in air. The
medium was changed every two days.
Contact cytotoxicity
Segments of acellular arteries (5 mm2) were incubated with
BHK and 3T3 cell lines in six well plates. Cells were seeded at
a density which would allow conﬂuency following 48 h incubation
at 37 C 5% (v/v) CO2 in the appropriate medium. Tissues were
adhered to the surface of the wells using collagen I extracted fromrat tail tendons. Cyanoacrylate glue and collagen alonewere used as
positive and negative controls respectively. Following incubation at
37 C 5% (v/v) CO2 for 24 h, the medium was aspirated and the cell
layers washed with DPBSa. The cells were ﬁxed with 10% (v/v)
neutral buffered formalin (Raymond A Lamb) and stained using
Giemsa solution (Merck R66 formulation, VWR, Lutterworth, UK)
for 5 min at room temperature. The wells were washed with
distilled water and allowed to air dry before examination using
an inverted Olympus IX 71 microscope. Images were captured
digitally.
Extract cytotoxicity
Segments from three acellular arteries and fresh controls were
ﬁnelymacerated and incubated in DMEMor GMEM for 72 h at 37 C
with agitation at a concentration of 100 mg ml1. Following incu-
bation the mixture was centrifuged at 600  g for 15 min and the
supernatant removed for cytotoxicity studies. Both BHK and 3T3
cells were grown to 80% conﬂuency in a 96 well tissue culture plate
in 5% (v/v) CO2 at 37 C. The growth medium was replaced with
100 ml of extract and 100 ml of fresh medium. The positive control
was 40% (v/v) dimethyl sulfoxide (Sigma, Dorset, UK) in DMEM and
the negative control was growthmedium and cells alone. After 48 h
incubation the ATP content of each well was determined as an
indicator of cell viability. The manufacturer’s instructions included
in the ATPlite-M kit (PerkineElmer, Cambridgeshire, UK) were
followed. Luminescencewas determined using a Topcount NX plate
reader (PerkineElmer).
Bacterial growth and identiﬁcation
The following microorganisms were purchased from the
National Collection of Type Cultures (NCTC) and were chosen as
they are some of the common organisms retrieved from vascular
graft infections10e12: Methicillin resistant Staphylococcus aureus
(MRSA NCTC 13297), Methicillin sensitive S. aureus MSSA (NCTC
8294), Staphylococcus epidermidis (NCTC 13360), Enterococcus fae-
calis (NCTC 12697), Escherichia coli (NCTC 11560), Pseudomonas
aeruginosa (NCTC 13359), Klebsiella pneumoniae (NCTC 204) and
Candida albicans (NCPF 3940). Strains were positively identiﬁed
using standard microbial techniques before use.
Microbial growth in liquid media
To prepare liquid cultures of microorganisms, a single colony
from a purity plate was removed with a sterile loop and used to
inoculate 10 ml of nutrient broth (Oxoid). Broths were incubated at
37 C for 18e24 h before being diluted with fresh nutrient broth
until an optical density which was comparable to a 0.5 McFarland
standard solution when assessed at 570 nm (OD ¼ 0.04) was
achieved.
Disk diffusion assay
This was based on the British Society of Antimicrobial Chemo-
therapy (BSAC) disk diffusion assay,13 performed to detect antimi-
crobial agents capable of diffusing through solid agar to inhibit
bacterial growth. Sections of material (6 mm) to be tested were
aseptically placed onto lawns of bacteria, which had been inocu-
lated onto Muller Hinton agar (MHA) plates for bacteria and Sab-
ouraud agar for C. albicans. The materials included fresh EIA,
acellular EIA, SIS, ePTFE and Dacron. The negative control was
a 6 mm ﬁlter membrane disk (Fischer Scientiﬁc Ltd) loaded with
DPBSa. The positive control was a disk loaded with a concentration
of an antibiotic which was above the minimum inhibitory
concentration of the organism used in the test, which varied
depending on the organism used. The antibiotics used were:
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biomedicals, Cambridge, UK) tobramycin, levoﬂoxacin and ﬂuco-
nazole (Oxoid). Each plate was repeated in triplicate and incubated
for 24 h at 37 C, except MRSA and MSSA plates, which were
incubated at 35 C for 24 h. The zone of inhibition was measured
and represented a direct measure of antimicrobial activity.
Extraction of materials into solutions
Known quantities of each vascular material were extracted into
solution to perform a broth minimum inhibitory concentration
assay. Two methods were used, the ﬁrst was as described above for
the extract cytotoxicity studies. The second was developed from
Sarikaya et al.6 and involved lyophilizing and powdering the
materials using a cryomil (Wolfe Laboratory supplies Ltd, York, UK).
The powder was then resuspended at 1 mg ml1 in DPBSa (Oxiod).
The two synthetic materials could not be used for these studies as
the materials were not soluble in medium.Minimum inhibitory concentration assay
Extracts of the vascular materials were incubated with standard
suspensions of microorganisms (0.5 McFarland standard) for
18e24 h at 37 C. Each 96well plate contained standard dilutions of
commercially available clinically relevant antimicrobial compounds
which varied depending on the microorganism. Concentrations of
64 to 0 mg ml1 were used. The growth of microbes was monitored
spectrophotometrically over a 24 h period. After incubation theMIC
was reported as the lowest concentration which produced an
optical density below 0.2 at 570 nm, which was conﬁrmed by visual
analysis of the plate as in Sarikaya et al.6Figure 1. Histological analysis of decellularised external iliac artery compared to fresh tiss
respectively. The absence of purple nuclei in 1(a)ii demonstrates removal of cells, whilst the
decellularised tissue, respectively. Fluorescently stained double stranded DNA is visible throu
tissue, indicating the removal of cells following decellularisation.Resistance to bioﬁlm initiation studies
Segments of vascular graft materials were prepared using
a 6 mm biopsy punch. Materials tested included: fresh porcine
EIA, acellular porcine EIA, Surgisis and Dacron with an internal
control of nitrocellulose (Fischer Scientiﬁc Ltd, control). Microbial
suspensions (OD ¼ 0.04 at 570 nm) were prepared from overnight
cultures of the organisms. The microbial suspension (20 ml) was
pipetted onto each material and incubated at 37 C for 18e24 h.
After incubation the disks were washed in sterile saline for 5 min
with gentle agitation to remove loosely attached organisms.
Organisms within the bioﬁlm were removed by incubating in
1 mg ml1 cellulase (From MP biomedicals, 60 U mg1 made in
0.05 M citrate buffer pH 4.6) for 30 min at 37 C followed by 30 s
vortexing and 5 min sonication at 30 mHz using a sonicating water
bath (Ultrawave, U50). The disks were removed to fresh saline and
macerated using a tissue homogenizer (IKA, T8.10). Each of the
suspensions (loosely attached, bioﬁlm and irreversibly bound)
were centrifuged for 20 min at 2000 g and the pellet containing
microbes resuspended in 5 ml sterile saline to wash the cells. Each
sample was decimally diluted in saline and plated onto Muller
Hinton agar plates. Following incubation at 37 C for 18e24 h plates
containing between 30 and 300 colonies were used to determine
the colony forming units (CFU) per 0.28 cm2 (the surface area of
each disk). The materials were tested in triplicate.Statistical analysis
The student’s t-test was used for comparison of twomeans. Data
with more than two groups were analysed using one way analysisue. a(i), a(ii) Haematoxylin and eosin staining of fresh tissue and decellularised tissue
architecture of the vessel wall was retained. b(i), b(ii) DAPI staining of fresh tissue and
ghout the entirety of the vessel in the fresh tissue and is absent from the decellularised
Figure 2. Extract cytotoxicity of decellularised porcine external iliac arteries (EIA). The
fresh and decellularised EIA samples were not signiﬁcantly different from the negative
control. Data expressed as mean (n ¼ 6)  95% conﬁdence limits. * Signiﬁcantly
different from the negative control (p < 0.05 ANOVA).
Figure 3. Disk diffusion assay. a(i), a(ii) Standard plate of MSSA and MRSA respectively with
The size of the inhibition zones is indicative of the degree of inhibition. b(i), b(ii) test plates
was loaded with 16 mg ml1vancomycin. Clockwise around the plate are fresh external iliac a
in the centre. No samples produced a zone of inhibition.
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were then determined by calculating the minimum signiﬁcant
difference (MSD) at p ¼ 0.05 using the T-method.14
Results
Validation of decellularisation
Following the decellularisation procedure, each of the porcine
EIAs was analysed to ensure all cells had been removed. H & E
staining demonstrated the loss of nuclei throughout the thickness
of the vessel (Fig. 1). This was supported by DAPI staining, which
demonstrated a lack of ﬂuorescently stained double stranded DNA
when compared to the fresh EIA control (Fig. 1d). The total DNA
remaining after decellularisation was quantiﬁed following extrac-
tion using a commercial kit. Decellularised EIA (0.0239 mg mg1)
demonstrated a 97% reduction in total DNA compared to the fresh
controls (0.6299 mg mg1).
Biocompatibility studies demonstrated that following decellu-
larisation the acellular EIA did not affect the growth of the two cell
lines (3T3 and BHK) as either whole tissue or tissue extracts (Fig. 2).
In the contact cytotoxicity assay cells lines grew up to the tissuevarious concentrations of vancomycin loaded onto disks (range from 0.5e16 mg ml1).
of MSSA and MRSA respectively. The positive control is shown at the top and this disk
rtery (EIA), acellular EIA, SIS, Dacron, ePTFE and a negative control loaded with DPBSa
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cytotoxicity the levels of ATP in the culture incubated with tissue
extracts was not signiﬁcantly lower than the negative control with
no tissue extract (analysed using an ANOVA, p < 0.05).
Disk diffusion assay
To assess the antimicrobial activity of any diffusible compounds
within the decellularised vessels, fresh tissue and the commercial
controls (SIS, ePTFE and Dacron), 5 mm segments were placed
onto lawns of bacteria and the zones of inhibitionmeasured at 24 h.
The positive control produced a zone of inhibition above the
breakpoint speciﬁed by BSAC. None of the materials tested
produced any zone of inhibition with any of the microorganisms
tested (Fig. 3).
Minimum inhibitory concentration assay
The ability of extracted samples to inhibit the visible growth of
microorganisms was determined using a MIC method described in
Sarikaya et al.6 The MIC for vancomycin against MRSA was
8 mg ml1 and against MSSA was 4 mg ml1 (Fig. 4). C. albicans,
a yeast, had a slightly different MIC method which is described in
the CLSI document M27-A3.
None of the graft materials tested inhibited the growth of
bacteria or C. albicans, including the SIS material (Fig. 5). The
method of extraction into solution did not have any effect on theFigure 4. Minimum inhibitory concentration of Vancomycin against MRSA and
MSSA. A MRSA with vancomycin. The dotted line represents the lowest concentration
where growth was visible. The concentration above this is reported as the MIC. The
MIC is 8 mg ml1 as this is the lowest concentration which produced an optical density
below 0.2. B MSSA with vancomycin. Here the MIC is 4 mg ml1. These MIC results are
in line with the British Society for Antimicrobial Chemotherapy (BSAC) published
breakpoints.ability to inhibit microbial growth. Although there was a slightly
reduced growth rate of E. faecalis when incubated with the SIS
extract, this was not enough to inhibit the visible growth of
bacteria, and therefore cannot be documented as antimicrobial
using these methods.
Resistance to bioﬁlm initiation
Segments of fresh EIA, acellular EIA, Surgisis and nitrocellu-
lose were inoculated with standard suspensions of bacteria and the
total CFU.0.28 cm2 recovered was compared to Dacron (Fig. 6).
Statistical analysis was performed using a one-way ANOVA. Bioﬁlm
formation occurs in developmental stages: reversible attachment
to a surface, irreversible attachment and bioﬁlm maturation
including exo-polysaccharide (EPS) production.15
In regard to the Gram positive organisms, the total CFU recov-
ered was signiﬁcantly lower than Dacron for all biological
materials tested, with the exception of E. faecalis where only the
total CFU recovered from the fresh EIA and acellular EIA were
signiﬁcantly lower than Dacron (Table 1). The difference between
the biological tissues and Dacronwas largely due to reductions in
the CFU loosely attached and within the bioﬁlm. For MSSA and
E. faecalis there was also a signiﬁcant reduction in CFU irreversibly
attached to the biological material when compared to Dacron.
When the graft materials were inoculated with the Gram
negative organisms the total CFU recovered for all materials was
again signiﬁcantly lower than the total CFU recovered from
Dacron.
When the graft materials were inoculated with C. albicans there
was a signiﬁcant reduction in the total CFU for both fresh EIA and
acellular EIA when compared with Dacron and this could be
attributed to a reduction in loosely attached CFU.
Discussion
Strategies to combat vascular conduit infections have centred on
impregnating or preloading synthetic materials with antimicrobial
cocktails to prevent the initiation of infection.16,17 These conduits,
although resistant to infection, still display the disadvantages of
synthetic materials. The effectiveness of rifampicin in reducing
vascular graft infections is currently disputed with some studies
indicating a signiﬁcant reduction in infection rates while others do
not.
It has long been suggested that biological grafts are more
resistant to infection in vivo,18,19 with some studies reporting SIS to
have antimicrobial properties.6 The aim of this study was to assess
the antimicrobial activity of acellular vascular conduits compared
to commercially used vascular graft materials ePTFE, Dacron and
Surgisis. Decellularisation of the porcine EIA materials was per-
formed using a proprietary method which removes over 90% of
DNA from the tissue, whilst retaining normal histioarchitecture.20
The biomechanical properties of tissues decellularised in this way
are comparable to fresh tissues.20
Using a modiﬁed disk diffusion method no detectable antimi-
crobial activity was observed for any material. This may have been
due to the inability of antimicrobial compounds to diffuse through
the agar to inhibit microbial growth. Previously used methods to
extract materials into solution include acid and heat treatment
which would likely be detrimental to any antimicrobial peptide or
proteins present.6,21In the present study, a gentler method of
extraction was used. There was no detectable antimicrobial activity
in whole tissue or powdered extract of decellularised porcine
arteries against any of the bacteria or yeast tested and this did not
support previous observations.6,18 The reported antimicrobial
activity of SIS could not be replicated in our laboratory with three
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Figure 6. Resistance to bioﬁlm formation of fresh tissue, acellular tissue, Surgisis and Dacron compared to a nitrocellulose control. Both fresh tissue and acellular (Dcell) tissue were
signiﬁcantly lower than Dacron when inoculated with all microorganisms. When inoculated with S. epidermidis, the microorganism most commonly found in vascular graft
infections, both fresh tissue and acellular (Dcell) tissue were signiﬁcantly lower than both Dacron and the disk controls, indicating a resistance to bioﬁlm initiation.
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the materials tested lacked antimicrobial activity. The previously
reported activity of SIS may have been due to the extraction
procedure creating peptide fragments with antimicrobial activity.
Many in vivo studies have suggested that although biological
materials are not antimicrobial they are resistant to infection.4,19 To
assess this, vascular graft materials were inoculated with various
bacteria and a yeast to determine their ability to resist bioﬁlm
formation. The non adherent organisms, the organisms in the
bioﬁlm and the organisms which had attached to the biomaterial
were recovered and compared to Dacron. The biological materials
(fresh EIA, acellular EIA and Surgisis) demonstrated a signiﬁcant
reduction in total CFU recovered when compared to Dacron in all
bacterial and yeast strains tested with the exception of E. faecalis
and C. albicans in which Surgisis was not signiﬁcantly different
from Dacron. These results are consistent with the literature.
Infection rates of synthetic vascular conduits differ depending upon
where the device is placed. For example the infection rate for aor-
tofemoral grafts is 0.5e1% greater than abdominal aorta grafts. This
increase in infection rate can be attributed to the increased
numbers of microbes residing in the groin region. As previously
noted, synthetic grafts are infected more frequently than autografts
or biological alternatives.4 Due to this propensity for infectionFigure 5. Minimum inhibitory concentration of powdered acellular porcine arteries incubat
intervals over 24 h incubation. The end point was determined as any optical density over 0
C. albicans. D) P. aeruginosa. E) MRSA. F) MSSA. G) S. epidermidis. H) E. faecalis. E. faecalis disp
this was not enough to visibly inhibit the bacterial growth and so cannot be considered antim
material. Decellularised porcine EIA, fresh porcine E and SIS materials were extracted intosynthetic materials should not be used in infected ﬁelds as
a secondary conduit, particularly when considering insertions
involving the groin region. A biological conduit, such as an auto-
graft which can resist bioﬁlm formation would be preferable.
However, since there is no harvestable autograft in some patients,
an acellular biological conduit may offer an alternative. Moreover,
acellular biological conduits could be used as alternative primary
grafts which would be readily available, decreasing operating
times. However, further studies are required to determine the
clinical utility of the acellular arterial conduit utilised in this study,
in particular the long term biomechanical stability and durability.
Previous studies have often investigated ePTFE which was not
included in the current study. Due to the hydrophobicity of ePTFE
we were unable to inoculate it consistently. There is currently
conﬂicting evidence as to whether there is a difference in infection
rates between ePTFE and Dacron.22
The antibiotics used in this study were by no means an
exhaustive list. They represented broad spectrum antibiotics
available to researchers which are clinically relevant to vascular
graft infections. In future studies other antibiotics could be inves-
tigated, such as tazocin or teicoplanin. To investigate all compounds
in clinical use against all possible organisms was not within the
scope of the present study.ed with various microorganisms. Spectophotometric readings at 570 nm were taken at
.2, which was conﬁrmed by visual analysis of the plate. A) E. coli. B) K. pneumoniae. C)
layed a reduced bacterial growth rate when incubated with extracted SIS material but
icrobial. All other microorganisms were not affected by the presence of powdered graft
solution; however none of the samples tested could inhibit bacterial growth.
Table 1
Resistance to bioﬁlm formation of various vascular graft materials (Fresh porcine EIA
(fresh), acellular porcine EIA (acell), Surgisis and Dacron) and a nitrocellulose disk
control (disk area ¼ 0.28 cm2). The bioﬁlm formed after 24 h incubation and was
collected as three stages, loosely attached microorganisms, microorganisms within
the bioﬁlm and microorganisms irreversibly attached to the biomaterial. The raw
data (CFU.0.28 cm2) was Log10 transformed. The Log10 CFU.0.28 cm2 that were
loosely attached, in the bioﬁlm, attached to the biomaterial and the total recovered
were expressed as percentages of Dacron. The raw data for each microorganismwas
analysed by one-way ANOVA and individual differences between means (biomate-
rial type) were determined using the T-method.
% Compared to Dacron
log CFU.
0.28 cm2
Loosely
attached
In
bioﬁlm
Attached to
biomaterial
TOTAL
MRSA Dacron 9.70 100.0 100.0 100.0 100.0
2.6$107
CFU added
Fresh 9.23 44.1* 13.8* 83.3 34.0*
Dcell 8.76 5.0* 24.4* 79.2 11.4*
Surgisis 9.04 12.9* 43.1* 66.7 22.0*
Disks 9.18 64.7 47.5* 14.2 30.0*
MSSA Dacron 9.49 100.0 100.0 100.0 100.0
2.8$107
CFU added
Fresh 9.00 28.4* 40.9* 13.0* 32.3*
Dcell 8.92 19.0* 41.8* 9.6* 26.8*
Surgisis 9.23 24.2* 109.1 27.6* 54.8*
Disks 8.15 26.8* 7.91* 7.0* 4.5*
CNS Dacron 9.44 100.0 100.0 100.0 100.0
1.4$106
CFU added
Fresh 8.18 5.5* 5.2* 19.6 5.5*
Dcell 8.20 6.2* 5.4* 17.4 5.7*
Surgisis 8.44 12.9* 8.2* 9.1 9.9*
Disks 8.89 46.1 18.2* 28.2 46.9*
E. faecalis Dacron 8.61 100.0 100.0 100.0 100.0
2.6$106
CFU added
Fresh 8.01 16.5* 36.6 4.3* 24.9*
Dcell 8.12 13.0* 56.0 5.5* 27.1*
Surgisis 8.46 49.8 95.1 49.2* 70.2
Disks 8.33 25.0* 89.1 5.7* 52.8
E. coli Dacron 8.94 100.0 100.0 100.0 100.0
1.9$105
CFU added
Fresh 8.33 18.5 29.3* 5.5* 24.7*
Dcell 8.46 42.7 31.1* 5.7* 32.9*
Surgisis 8.56 35.6 40.6* 87.1 42.0*
Disks 8.81 89.9 67.1 76.7 74.2
Klebsiella Dacron 9.06 100 100 100 100
2.8$105
CFU added
Fresh 8.77 39.1 62.1 52.1* 50.5*
Dcell 8.76 38.5 60.7 66.8* 49.5*
Surgisis 8.80 36.3 66.7 93.6 53.9*
Disks 8.81 85.5 33.4* 42.1* 56.2*
Pseudomonas Dacron 7.85 100.0 100.0 100.0 100.0
4.3$105
CFU added
Fresh 7.54 25.1 28.7 0.4* 48.9*
Dcell 7.63 37.9 30.2 0.4* 59.9*
Surgisis 7.74 81.2 32.8 21.2* 76.7*
Disks 7.53 63.9 30.2 0.5* 47.4*
C. albicans Dacron 7.76 100.0 100.0 100.0 100.0
4.7$105
CFU added
Fresh 7.41 38.8* 79.9 40.7 53.1*
Dcell 7.63 62.8* 103.4 52.2 87.6*
Surgisis 7.65 74.9 82.2 101.4 81.6
Disks 7.46 48.4* 57.0 35.7 59*
* ¼ Signiﬁcantly lower than Dacron p < 0.05.
K. Owen et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 573e581580Further studies will investigate the utility of impregnating
acellular arteries with antimicrobial cocktails, which is a similar
strategy that researchers investigating synthetic materials have
undertaken to produce a vascular graft material which can resist
infection.
Conclusions
In the present study no antimicrobial activity of biological
vascular graft materials was detected using a modiﬁed diskdiffusion assay or a minimum inhibitory concentration assay. It was
found that biological materials could resist bioﬁlm formation to
a greater extent than Dacron for a range of microorganisms,
which is consistent with clinical observations.
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